Epilepsy in the Renaissance: A survey of remedies from 16th and 17th century German herbals |
| |
Authors: | Michael Adams Sarah-Vanessa Schneider Martin Kluge Michael Kessler Matthias Hamburger |
| |
Affiliation: | 1. Department of Pharmaceutical Sciences, Division of Pharmaceutical Biology, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland;2. Swiss Pharmaceutical Museum, University of Basel, Totengässlein 3, CH-4051 Basel, Switzerland |
| |
Abstract: | Ethnopharmacological relevanceBefore modern anticonvulsive drugs were developed people in central Europe used herbal remedies to treat epilepsy. Hundreds of different plants for this indication can be found in German herbals of the 16th and 17th centuries. Here we compile these plants and discuss their use from a pharmacological perspective.Materials and methodsNine of the most important European herbals of the 16th and 17th century including Bock (1577), Fuchs (1543), Mattioli (1590), 103 and 104, Brunfels (1532), Zwinger (1696), and Tabernaemontanus (1591, 1678) were searched for terms related to epilepsy, and plants and recipes described for its treatment were documented. We then searched scientific literature for pharmacological evidence of their effectiveness. Additionally the overlapping of these remedies with those in De Materia Medica by the Greek physician Dioscorides was studied.ResultsTwo hundred twenty one plants were identified in the herbals to be used in the context of epilepsy. In vitro and/or in vivo pharmacological data somehow related to the indication epilepsy was found for less than 5% of these plants. Less than 7% of epilepsy remedies are in common with De Materia Medica.ConclusionsNumerous plants were used to treat epilepsy in the 16th and 17th centuries. However, few of these plants have been investigated with respect to pharmacological activity on epilepsy related targets. |
| |
Keywords: | AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid BAC, Baclofen BMC, Bicucullin CA1-neurons, Neurones from the CA1 region of the hippocampus CC(T), Computer tomography [3H]5,7-DCKA, 5,7-dichlor kynurenic acid EBOB, 4&prime -ethynyl-4-n-[2,3-(3)H(2)]propylbicycloorthobenzoate EEG, Electroencephalography FCS, Fluorescence-correlation-spectroscopy [3H]FNT, [3H]Flunitrazepam GABA, Gamma amino butyric acid GABA-T, GABA-transaminase GAD, Glutamate decarboxylase GBL, γ-butyrolacton GBZ, The vehicle registration code of Gibraltar GH4C1-cells, Rat hypophyse cell line I.m., Intramuscularly INH, Isoniazid I.p., Intraperitoneally KA, Kainic acid MAO, Monoamine oxidase MES, Maximal electroshock seizure threshold model MRS, Magnetic resonance spectroscopy MRT, Magnetic resonance tomography NMDA, N-methyl d-aspartate NMRI-mice, Mouse strain from the Naval Medical Research Institute MTT, 3-(4,5-Dimethylthiazol-2-yl)-2,5, Diphenyltetrazoliumbromid PET, Positron emission tomography PTZ, Pentylenetetrazole PTX, Picrotoxin PTZ, Pentylenetetrazole [35S]TBPS, [35S]T, Butylbicyclophosphorothionate SPECT, Single-photon-emission-computer tomography |
本文献已被 ScienceDirect 等数据库收录! |
|